2m 2m 2m 2m 2m 2m 2m
CONTEXT THERAP (CNTX)
NASDAQ
$0.32+$0.003 (+0.83%)
Price as of Oct 02, 2026 5:52 PM EDT- $28.9MMarket Cap
- -68.55%1-Year Change
- BiotechnologyIndustry
CONTEXT THERAP (CNTX)
$0.32+$0.003 (+0.83%)
CNTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.31 | ||
Change | +$0.01 (+4.66%) | ||
Open | $0.31 | ||
High | $0.32 | ||
Low | $0.30 | ||
Previous Close | $0.30 | ||
Volume | 1,140,604 | ||
30-Day Average Volume | 1,202,101 | ||
1-Week Change | -15.28% | ||
1-Month Change | -13.70% | ||
1-Year Change | -68.55% | ||
3-Year Change | -79.18% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 91.9M | ||
Total Assets | $46.1M | ||
Market Cap | $28.9M | ||
Enterprise Value | -$14.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$14.6M | ||
Free Cash Flow | -$7.0M | ||
EBIT | -$14.6M | ||
EBITDA | -$14.6M | ||
Net Working Capital | $37.9M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue